PropertyValue
?:creator
?:doi
?:doi
  • 10.1136/bmj.n309
?:journal
  • BMJ
?:license
  • unk
?:pmid
?:pmid
  • 33531342.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Covid-19: Russian vaccine efficacy is 91.6%, show phase III trial results.
?:type
?:year
  • 2021-02-02

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ca3w6h98>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ca3w6h98>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all